Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-9,040
Closed -$410K 473
2017
Q2
$410K Buy
+9,040
New +$399K 0.04% 432
2016
Q3
Sell
-37,126
Closed -$1.28M 970
2016
Q2
$1.28M Sell
37,126
-166,423
-82% -$5.76M 0.06% 390
2016
Q1
$7.02M Buy
+203,549
New +$7.1M 0.42% 42
2014
Q4
Sell
-26,510
Closed -$645K 512
2014
Q3
$645K Buy
+26,510
New +$669K 0.26% 127
2013
Q3
Sell
-24,138
Closed -$466K 364
2013
Q2
$466K Buy
+24,138
New +$504K 0.15% 142

Other funds holding HOLX

Clinton Group's HOLX Position: Q3 2017 in Review

Clinton Group sold out of Hologic (HOLX) in Q3 2017, closing a stake of 9,040 shares — an estimated $410K sold.

Clinton Group first reported a position in HOLX in Q2 2013 and held it in 5 quarters. The position peaked at $7.02M in Q1 2016. 457 funds tracked by Wall St. Rank hold HOLX as of Q3 2017.

  • Clinton Group reported no remaining Hologic position as of Q3 2017 after selling out during the quarter.
  • Clinton Group sold 9,040 Hologic shares in Q3 2017, an estimated $410K.
  • Clinton Group first reported a position in Hologic in Q2 2013 and held it in 5 quarters.
  • Clinton Group's Hologic position peaked at $7.02M in Q1 2016.
  • 457 funds tracked by Wall St. Rank held Hologic as of Q3 2017.

Based on Clinton Group's 13F filing for Q3 2017, filed 14 Nov 2017.